Lexicon Pharmaceuticals Announces The Peer-Reviewed Journal Of American Society Of Nephrology Has Published A Research Paper Analyzing The Efficacy And Safety Of Sotagliflozin, A Dual SGLT1 And SGLT2 Inhibitor, When Added To Insulin In Patients With Type